Atrial fibrillation (AF) is the most common sustained atrial arrhythmia conferring a higher
morbidity and mortality. Despite the increasing incidence of AF; available therapies are far …

Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical
practice with growing prevalence in developed countries. Several medical and …

Background—There is epidemiological evidence that omega-3 polyunsaturated fatty acids
(PUFAs) reduce the risk of atrial fibrillation (AF), but clinical data are conflicting. The present …

Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting more than 2.6 million
people in the United States. It occurs frequently after myocardial infarction and is the most …

Omega-3 polyunsaturated fatty acids (PUFAs), commonly found in fish oils, have exhibited
many beneficial effects on the cardiovascular system including a reduction in the incidence …

The efficacy and safety of omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the
prevention of atrial fibrillation (AF) is a source of ongoing debate in the current literature …

Background: The main dietary source of omega-3 polyunsaturated fatty acids (n-3 PUFA) is
fish, which contains eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). In the …

Atrial fibrillation (AF) is the most prevalent arrhythmia and is associated with considerable
morbidity and mortality. Available pharmacologic antiarrhythmic therapies are often …

Background The effects of omega-3 fatty acids (PUFA) on the prevention of atrial fibrillation
(AF) appear to contrast between several randomized controlled trials (RCTs). Therefore, we …

Several reports from population-based surveys and large randomized clinical trials have
shown a remarkable 45–68% reduction in the rates of sudden cardiac death (presumably …